Japan-based Towa Pharmaceutical Co Ltd (TYO: 4553) has completed its acquisition of Esteve's generics division, including United States-based Breckenridge Pharmaceutical Inc, it was reported on Friday.
Towa Pharmaceutical Co Ltd has been active since 1951 and is focused on research and development, production, and marketing of generic drugs.
The Japan-based company, which has more than 3,100 employees, posted annual sales of JPY105,104m for the year ended 31 March 2019.
(USD1=JPY108)
ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic
ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA
International Isotopes Inc to change name to Radnostix Inc
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
EirGenix signs second global exclusive licensing deal with Sandoz
Padagis invests USD36m to expand manufacturing in Minneapolis
Newbury Pharmaceuticals gains Danish approval for generic ivermectin cream